Omar Elaskalani

Omar Elaskalani is an Honorary Research Associate at The University of Western Australia (UWA), affiliated with the UWA Medical School and the UWA Centre for Child Health Research (linked to The Kids Research Institute Australia). His research focuses on cancer biology, immunotherapy, and pharmacology, with a particular emphasis on mechanisms of chemoresistance, immune checkpoint blockade, and antiplatelet drug interactions in oncology.

• University Affiliation: The University of Western Australia
• School: UWA Medical School

His work contributes to Sustainable Development Goals related to health and well-being. Key research areas include pancreatic cancer, tumor immunity, and molecular pathways in leukemia. Recent studies explore combination therapies targeting immune checkpoints and novel drug mechanisms.

Elaskalani leads or collaborates on grants focusing on pediatric oncology drug targets and translational cancer research. Notable projects include 'Building translational capacity in WA' and 'Kids are not small adults: identifying age-dependent drug targets'. He has authored or co-authored 9 peer-reviewed publications, with significant contributions in Journal for Immunotherapy of Cancer and Cancers.

His research has been cited over 395 times, reflecting impactful contributions to cancer drug development and immunotherapy strategies.